Futura Medical PLC Result of AGM (1158I)
June 14 2017 - 12:00PM
UK Regulatory
TIDMFUM
RNS Number : 1158I
Futura Medical PLC
14 June 2017
For immediate release 14 June 2017
Futura Medical plc
("Futura" or "the Company")
Result of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology, confirms that all
resolutions were duly passed at its Annual General Meeting held
today.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0)1483 685
670
mail to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0)20 7466 5000
/ Stephanie Watson
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGUSVVRBNANAAR
(END) Dow Jones Newswires
June 14, 2017 12:00 ET (16:00 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024